24 related articles for article (PubMed ID: 4006159)
1. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
[TBL] [Abstract][Full Text] [Related]
2. Ethical issues arising from medical research.
Hamilton MP
Isr J Med Sci; 1983 May; 19(5):431-6. PubMed ID: 6345463
[TBL] [Abstract][Full Text] [Related]
3. The IRB as deputy sheriff: proposed FDA regulation of the institutional review board.
Huff TA
Clin Res; 1979 Apr; 27(2):103-8. PubMed ID: 10241072
[No Abstract] [Full Text] [Related]
4. More tales from institutional review boards.
Neuhauser D
Health Matrix Clevel; 1994; 4(1):153-8. PubMed ID: 10142174
[No Abstract] [Full Text] [Related]
5. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
Nightingale SL
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs and research.
Tueting P
Psychiatr Med; 1991; 9(2):333-47. PubMed ID: 1857767
[TBL] [Abstract][Full Text] [Related]
7. Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration.
Varley CK
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):292-4. PubMed ID: 17630861
[No Abstract] [Full Text] [Related]
8. Clinical trials at AHCs: the perspective of an academic clinical trials office.
Paller MS; Hostetler L; Dykhuis DA
Acad Med; 2002 Dec; 77(12 Pt 1):1201-6. PubMed ID: 12480622
[TBL] [Abstract][Full Text] [Related]
9. Managing the informed consent process in large multicenter projects.
Mark BA; Geddes N; Salyer J; Smith CS
Nurs Res; 1999; 48(2):114-7. PubMed ID: 10190839
[No Abstract] [Full Text] [Related]
10. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
Mavilio F
Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
[TBL] [Abstract][Full Text] [Related]
11. Institutional review boards and collaborations between academia and industry: some counterproductive policies and practices.
Levine RJ
Circulation; 1985 Aug; 72(2 Pt 2):I48-50. PubMed ID: 4006159
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
